skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis
Lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis

Vivian F. do Amaral Sérgio Paulo Bydlowski; T. C Peranovich; Paula A. A. S Navarro; M. T. R Subbiah; Rui Alberto Ferriani

European Journal of Obstetrics & Gynecology and Reproductive Biology Co. Clare v. 119, p. 72-75, 2005

Co. Clare 2005

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1439812 )(Acessar)

2
Lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis
Lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis

Vivian F. do Amaral Sérgio Paulo Bydlowski; T. C Peranovich; Paula A. A. S Navarro; M. T. R Subbiah; Rui Alberto Ferriani

European Journal of Obstetrics & Gynecology and Reproductive Biology Co. Clare v. 119, p. 72-75, 2005

Co. Clare 2005

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1439812 )(Acessar)

3
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations

Subbiah, V. ; Shen, T. ; Terzyan, S.S. ; Liu, X. ; Hu, X. ; Patel, K.P. ; Hu, M. ; Cabanillas, M. ; Behrang, A. ; Meric-Bernstam, F. ; Vo, P.T.T. ; Mooers, B.H.M. ; Wu, J.

Annals of oncology, 2021-02, Vol.32 (2), p.261-268 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians
The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians
Material Type:
Artigo 		Adicionar ao Meu Espaço

The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians

Subbiah, V. ; Solit, D.B. ; Chan, T.A. ; Kurzrock, R.

Annals of oncology, 2020-09, Vol.31 (9), p.1115-1118 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Translating immuno-onco-microbiome-based therapeutics: precision bugs for immune checkpoint drugs
Translating immuno-onco-microbiome-based therapeutics: precision bugs for immune checkpoint drugs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Translating immuno-onco-microbiome-based therapeutics: precision bugs for immune checkpoint drugs

Subbiah, V. ; Pant, S.

Annals of oncology, 2023-06, Vol.34 (6), p.503-506 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Advances in cancer research dissemination through the pandemic and beyond
Advances in cancer research dissemination through the pandemic and beyond
Material Type:
Artigo 		Adicionar ao Meu Espaço

Advances in cancer research dissemination through the pandemic and beyond

Desai, A. ; Subbiah, I.M. ; Subbiah, V.

Annals of oncology, 2021-06, Vol.32 (6), p.689-693 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies

Subbiah, V. ; Iannotti, N.O. ; Gutierrez, M. ; Smith, D.C. ; Féliz, L. ; Lihou, C.F. ; Tian, C. ; Silverman, I.M. ; Ji, T. ; Saleh, M.

Annals of oncology, 2022-05, Vol.33 (5), p.522-533 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Subbiah, V. ; Kreitman, R.J. ; Wainberg, Z.A. ; Cho, J.Y. ; Schellens, J.H.M. ; Soria, J.C. ; Wen, P.Y. ; Zielinski, C.C. ; Cabanillas, M.E. ; Boran, A. ; Ilankumaran, P. ; Burgess, P. ; Romero Salas, T. ; Keam, B.

Annals of oncology, 2022-04, Vol.33 (4), p.406-415 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Precision oncology for biliary tract tumors: it’s written in blood
Precision oncology for biliary tract tumors: it’s written in blood
Material Type:
Artigo 		Adicionar ao Meu Espaço

Precision oncology for biliary tract tumors: it’s written in blood

Gouda, M.A. ; Subbiah, V.

Annals of oncology, 2022-12, Vol.33 (12), p.1209-1211 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
Material Type:
Artigo 		Adicionar ao Meu Espaço

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

Belli, C. ; Penault-Llorca, F. ; Ladanyi, M. ; Normanno, N. ; Scoazec, J.-Y. ; Lacroix, L. ; Reis-Filho, J.S. ; Subbiah, V. ; Gainor, J.F. ; Endris, V. ; Repetto, M. ; Drilon, A. ; Scarpa, A. ; André, F. ; Douillard, J.-Y. ; Curigliano, G.

Annals of oncology, 2021-03, Vol.32 (3), p.337-350 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (474)
  2. Anais de Congresso  (58)
  3. Reports  (5)
  4. Patentes  (2)
  5. Conjunto de Dados  (2)
  6. magazinearticle  (1)
  7. Book Chapters  (1)
  8. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1981  (13)
  2. 1981Até1993  (21)
  3. 1994Até2005  (37)
  4. 2006Até2015  (109)
  5. Após 2015  (363)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (542)
  2. Japonês  (16)
  3. Português  (1)
  4. Chinês  (1)
  5. Alemão  (1)
  6. Espanhol  (1)
  7. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Subbiah, M
  2. Peranovich, T
  3. Navarro, P
  4. Ferriani, R
  5. Amaral, V

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Technology
  4. Humans
  5. Oncology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.